Market news
AI stories from official filings plus the latest market headlines — in one place
D. E. Shaw & Co. Updates Stake in Gossamer Bio: Re-evaluating Strategy
The hedge fund giant updated its 13D filing regarding its holdings in biotech company Gossamer Bio.
D. E. Shaw & Co, L.P., one of the world's largest and most influential hedge funds, updated its 13D filing on July 24, 2026, concerning its existing holdings in the biotechnology company Gossamer Bio, Inc. ($GOSS). This 13D/A filing reflects changes in the fund's holdings, which could include additional purchases or sales, or a shift in its investment intentions.
Sources
Stories are auto-written from official filings and financial press, with AI assistance. Inaccuracies are possible; 13F filings lag by up to 45 days. For research only — not investment advice or a recommendation.